Yuan Qi

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Nuclear export of R-loop by the DDX1 and XPO1 complex promotes senescence-associated secretory phenotype and inflammaging

  Nature Aging · 2026-06-16

• Regulation of mitochondrial ROS by C15ORF48 in a basal cell subpopulation contributes to chemotherapy resistance in TNBC

  Science Advances · 2026-04-03

• Abstract 370: Low physiological pH drives P300 mediated acetylation of PARP1 and promotes PARP inhibitor resistance.

  Cancer Research · 2026-04-03

• Synergistically improving the properties of gelatin-based edible films with hydroxypropyl distarch phosphate and pre-gelatinized starch for convenience food packaging applications

  Food Hydrocolloids · 2026-01-08 · 2 citations

• Unraveling the tunnel dynamics of enzymes: a rational design strategy for robust biocatalysis in organic solventsPreprint

  SSRN Electronic Journal · 2026-01-01

• Nature-Inspired Continuous N-C Chain Elongation Enables Sustainable Peptide Synthesis

  ChemRxiv · 2025-12-16

• Stromal fibroblastic mutant Trp53 promotes mammary tumor development via enhanced secretion of paracrine factors

  npj Breast Cancer · 2025-12-12

• RNPS1 Promotes the Progression of Nonsmall Cell Lung Cancer via ETV4-Mediated Ferroptosis

  DNA and Cell Biology · 2025-12-11

• Supplementary Tables S1-S9 and Figures S1-S9 from Dimeric p53 Mutant Elicits Unique Tumor-Suppressive Activities through an Altered Metabolic Program

  2025-12-11

• Redox-responsive chitosan hydrogel releases mitochondria-targeted fullerenol to reprogram M1/M2 macrophage balance for diabetic wound healing

  Journal of Controlled Release · 2025-12-08 · 4 citations

• Supplementary Figure S8 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy

  2025-11-03

• Supplementary Table S2 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy

  2025-11-03

• Supplementary Figure S7 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy

  2025-11-03

• Supplementary Table S4 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy

  2025-11-03

• Supplementary Figure S6 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy

  2025-11-03

• Supplementary Table S1 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy

  2025-11-03

• Supplementary Figure S5 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy

  2025-11-03

• Supplementary Figure S10 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy

  2025-11-03

• Supplementary Figure S4 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy

  2025-11-03

• Supplementary Figure S9 from An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples during Neoadjuvant Chemotherapy

  2025-11-03